Literature DB >> 26866493

Botulinum Toxin: Preparations for Clinical Use, Immunogenicity, Side Effects, and Safety Profile.

Khashayar Dashtipour1, Farzin Pedouim1.   

Abstract

Botulinum toxin (BoNT) formulations are being used for a variety of medical applications. The use of BoNT preparations is continuously expanding with new formulations and indications. Of the seven antigenically distinct BoNTs, only two serotypes, type A and type B are commonly available for therapeutic use. The four available BoNT products are not equivalent and the knowledge of their formulations is crucial for product selection, avoidance of medication errors, therapeutic efficacy and safety. Generally, BoNT injection is a safe procedure when administered by an experienced injector. Side effects are always transient, and in the majority of cases they are mild and tolerable. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Mesh:

Substances:

Year:  2016        PMID: 26866493     DOI: 10.1055/s-0035-1571213

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  8 in total

Review 1.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

2.  Adverse Events Associated With Botox as Reported in a Food and Drug Administration Database.

Authors:  Salma Ahsanuddin; Savannah Roy; Wissam Nasser; Roman Povolotskiy; Boris Paskhover
Journal:  Aesthetic Plast Surg       Date:  2020-10-30       Impact factor: 2.326

3.  EUS-Guided Intragastric Injection of Botulinum Toxin A in the Preoperative Treatment of Super-Obese Patients: a Randomized Clinical Trial.

Authors:  Eduardo Guimarães Hourneaux de Moura; Igor Braga Ribeiro; Mariana Souza Varela Frazão; Luiz Henrique Mazzonetto Mestieri; Diogo Turiani Hourneaux de Moura; Creusa Maria Roveri Dal Bó; Vitor Ottoboni Brunaldi; Eduardo Turiani Hourneaux de Moura; Gabriel Cairo Nunes; Fábio Alberto Castillo Bustamante; Manoel Dos Passos Galvão Neto; Sergio Eiji Matuguma; Wanderley Marques Bernardo; Marco Aurélio Santo
Journal:  Obes Surg       Date:  2019-01       Impact factor: 4.129

Review 4.  The Use of Botulinum Toxin A in the Management of Trigeminal Neuralgia: a Systematic Literature Review.

Authors:  Anton Rubis; Gintaras Juodzbalys
Journal:  J Oral Maxillofac Res       Date:  2020-06-30

Review 5.  The Efficacy and Safety of Botulinum Toxin Injections in Preventing Postoperative Scars and Improving Scar Quality: A Systematic Review and Meta-Analysis.

Authors:  Zhihua Qiao; Haojun Yang; Lewei Jin; Sandi Li; Xiancheng Wang
Journal:  Aesthetic Plast Surg       Date:  2021-03-05       Impact factor: 2.708

6.  The Effect of Low Dose OnabotulinumtoxinA on Cervical Dystonia in Hypermobile Ehlers-Danlos Syndrome.

Authors:  Tina J Wang; Antonio Stecco; Khashayar Dashtipour
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2021-10-25

7.  Neurotoxin Impurities: A Review of Threats to Efficacy.

Authors:  Je-Young Park; Owen Sunga; Rungsima Wanitphakdeedecha; Jürgen Frevert
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-01-24

8.  Acral Necrosis in a COVID-19-Infected Man Treated with Botulinum Toxin Type A.

Authors:  Mette Soelberg Schjødt; Rikke Bech; Anne Braae Olesen
Journal:  Case Rep Dermatol       Date:  2021-12-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.